Thomas Braxton King, President & CEO at Alexza Pharmaceuticals Inc. (ALXA), sold 11,116 shares at $4.14 ($41K) on 2012-08-27, disclosed to the SEC on 2012-08-29.
Scheduled sale ($41k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,116 | $0 | 0.0% |
| 2 | $4.14 | 10,000 | $41K | 100.0% |
| Total | $3.72 avg | 11,116 | $41K | 100% |
| Filing → |
| ALXA | SELL | 2012-06-08 | $22K | — | Filing → |
| ALXA | SELL | 2009-12-21 | $100K | — | Filing → |
| ALXA | SELL | 2009-12-18 | $100K | — | Filing → |